Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10% that is the lowest of all cancer types [...
The role of the tumor suppressor mothers against decapentaplegic homolog 4 (SMAD4) has not yet been ...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by extensive local...
Background: Smad4, Smad6 and Smad7 are important molecules in TGF-beta pathway, which plays an impor...
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its incidence ...
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its incidence ...
Purpose: SMAD4 (also called Dpc4) is a tumor suppressor in the TGF-beta signaling(1) pathway that is...
[[abstract]]BACKGROUND:SMAD4 is a gastrointestinal malignancy-specific tumor suppressor gene found m...
Abstract Background Smad4 is the common mediator of the tumor suppressive functions of TGF-beta. Sma...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal human cancers due to its complicate...
Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in North Ame...
Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in North Ame...
<div><p>Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in N...
Pancreatic Ductal Adenocarcinoma (PDAC) is a particularly insidious and aggressive disease that caus...
DPC4/SMAD4 mutations are associated with aggressive pancreatic cancer. In this issue of Cell, Whittl...
Pancreatic adenocarcinoma (PDAC) putatively arises from the pancreatic duct, thus usage of the norma...
The role of the tumor suppressor mothers against decapentaplegic homolog 4 (SMAD4) has not yet been ...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by extensive local...
Background: Smad4, Smad6 and Smad7 are important molecules in TGF-beta pathway, which plays an impor...
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its incidence ...
Pancreatic ductal adenocarcinoma (PDAC) presents a five-year survival rate of 10% and its incidence ...
Purpose: SMAD4 (also called Dpc4) is a tumor suppressor in the TGF-beta signaling(1) pathway that is...
[[abstract]]BACKGROUND:SMAD4 is a gastrointestinal malignancy-specific tumor suppressor gene found m...
Abstract Background Smad4 is the common mediator of the tumor suppressive functions of TGF-beta. Sma...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal human cancers due to its complicate...
Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in North Ame...
Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in North Ame...
<div><p>Pancreatic ductal adenocarcinoma (PDAC) is the fourth most common cause of cancer death in N...
Pancreatic Ductal Adenocarcinoma (PDAC) is a particularly insidious and aggressive disease that caus...
DPC4/SMAD4 mutations are associated with aggressive pancreatic cancer. In this issue of Cell, Whittl...
Pancreatic adenocarcinoma (PDAC) putatively arises from the pancreatic duct, thus usage of the norma...
The role of the tumor suppressor mothers against decapentaplegic homolog 4 (SMAD4) has not yet been ...
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by extensive local...
Background: Smad4, Smad6 and Smad7 are important molecules in TGF-beta pathway, which plays an impor...